Human latent GDF-8 Protein, His Tag, low endotoxin (pro & latent) (MALS verified)

사용자 리뷰
제품 번호/규격
가격
수량
GD8-H5243-50ug
$415.00
GD8-H5243-500ug (250ug X 2)
$3265.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

  • Synonyms

    GDF-8, Myostatin, GDF8, MSTN, Growth, differentiation factor 8

  • Source

    Human latent GDF-8, His Tag (GD8-H5243) is expressed from human 293 cells (HEK293). It contains AA Asn 24 - Ser 375 (Accession # O14793-1).

    Predicted N-terminus: His

    Request for sequence
  • Molecular Characterization

    GDF-8 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the N-terminus. Pro-GDF8 was predominantly migrated to 45-50 kDa precursor monomers, and latent GDF8 showed 35 kDa prodomain monomer bands together with a 14 kDa growth factor monomer when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).

    The protein is designed as a dimer.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, 0.2 M Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

  • SDS-PAGE

    GDF-8 SDS-PAGE

    Human latent GDF-8, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    GDF-8 SEC-MALS

    The purity of Human latent GDF-8, His Tag (Cat. No. GD8-H5243) is more than 95% and the molecular weight of this protein is around 80-95 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     GDF-8 ELISA

    Immobilized Human latent GDF-8, His Tag (Cat. No. GD8-H5243) at 1 μg/mL (100 μL/well) can bind Biotinylated Human Activin RIIB Protein, Fc,Avitag (Cat. No. ACB-H82F3) with a linear range of 0.2-6 ng/mL (QC tested).

    Protocol
  •  GDF-8 ELISA

    Immobilized Human latent GDF-8, His Tag (Cat. No. GD8-H5243) at 1 μg/mL (100 μL/well) can bind Human Follistatin Protein, Fc Tag (Cat. No. FON-H5256) with a linear range of 0.8-25 ng/mL (Routinely tested).

    Protocol
  • Bioactivity-SPR

     GDF-8 SPR

    Human Follistatin Protein, His Tag, premium grade (Cat. No. FON-H52H4) immobilized on CM5 Chip can bind Human latent GDF-8, His Tag (Cat. No. GD8-H5243) with an affinity constant of 364 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  •  GDF-8 SPR

    Apitegromab captured on Protein A Chip can bind Human latent GDF-8, His Tag (Cat. No. GD8-H5243) with an affinity constant of 9.44 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol

사용자 리뷰
댓글 남기기

배경 소개

Growth differentiation factor 8 (GDF8), also known as myostatin, is a unique member of the transforming growth factor-β superfamily that is expressed in human granulosa cells and has important roles in regulating a variety of ovarian functions. GDF8 acts as a negative regulator of skeletal muscle growth and differentiation. In addition to the expression in the musculoskeletal system, GDF8 is also expressed in various tissues, including the reproductive system.

프론티어 진행

 
의약품 개발 진행
  • 영어 이름:

    Growth/differentiation factor 8

  • 카테고리:

  • 상장 의약품 수:

    0 상세

  • 임상 의약품 수:

    8 상세

  • 최고 개발 단계:

    NDA/BLA

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
  • 배경
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호